您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > RB394
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
RB394
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
RB394图片
CAS NO:1830320-32-5
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议
25mg电议

产品介绍
Cas No.1830320-32-5
化学名α-ethyl-4-[[[[4-methoxy-2-(trifluoromethyl)phenyl]methyl]amino]carbonyl]-benzenepropanoic acid
Canonical SMILESCOC1=CC(C(F)(F)F)=C(CNC(C2=CC=C(CC(C(O)=O)CC)C=C2)=O)C=C1
分子式C21H22F3NO4
分子量409.4
溶解度≤5mg/ml in ethanol;33mg/ml in DMSO;25mg/ml in dimethyl formamide
储存条件Store at -20℃
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

RB394 is an orally bioavailable and dual modulator of soluble epoxide hydrolase (sEH) and PPARγ [1].

Soluble epoxide hydrolase (sEH) is a bifunctional enzyme involved in the in vivo metabolism of endogenous lipid epoxides. The sEH is abundantly expressed in adipose tissue. sEH is an enzyme of the arachidonic acid cascade, promoting the hydrolysis of cytochrome P450 derived epoxyeicosatrienoic acids (EETs). Endothelial cell-derived EETs activate calcium-activated potassium channels on smooth muscle cells, leading to hyperpolarization and vascular relaxation. PPARγ, a member of the PPAR nuclear receptor family, plays an important role in adipogenesis, regulation of lipid metabolism and glucose homeostasis, and anti-inflammatory processes [1].

RB394 inhibited the activity of sEH with an IC50 of 0.33 μM and activated PPARγ with an EC50 of 0.3 μM. RB394 was inactive at PPARδ and showed 29% activation of PPARαat 10 μM. In mice, treatment with 30 mg/kg RB394 in drinking water for two weeks resulted in a final plasma concentration of ~3 μM. RB394 upregulated the PPARγ target genes, as well as PPARα and PPARδ in mouse livers [1].

References:
[1] Blocher R, Lamers C, Wittmann S K, et al.  N-Benzylbenzamides: a novel merged scaffold for orally available dual soluble epoxide hydrolase/peroxisome proliferator-activated receptor γ modulators[J]. Journal of medicinal chemistry, 2015, 59(1): 61-81.